Publicacións nas que colabora con Francisco Blanco García (119)

2024

  1. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

    Frontiers in Pharmacology, Vol. 15

  2. Genomic data from a pharmacogenetic study based on the efficacy of Tocilizumab in severe COVID-19 patients

    Zenodo

  3. Genomic data from a pharmacogenetic study based on the efficacy of Tocilizumab in severe COVID-19 patients

    Zenodo

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. Generation of human immortalized chondrocytes from osteoarthritic and healthy cartilage A NEW TOOL FOR CARTILAGE PATHOPHYSIOLOGY STUDIES

    Bone and Joint Research, Vol. 12, Núm. 1, pp. 46-57

  3. Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

    BMC musculoskeletal disorders, Vol. 24, Núm. 1, pp. 246

2022

  1. Antifibrotic effect of brown algae-derived fucoidans on osteoarthritic fibroblast-like synoviocytes

    Carbohydrate Polymers, Vol. 282

  2. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies

    Frontiers in Medicine, Vol. 9

  3. Reduced Levels of H2S in Diabetes-Associated Osteoarthritis Are Linked to Hyperglycaemia, Nrf-2/HO-1 Signalling Downregulation and Chondrocyte Dysfunction

    Antioxidants, Vol. 11, Núm. 4

2021

  1. Association of accelerated dynamics of telomere sequence loss in peripheral blood leukocytes with incident knee osteoarthritis in Osteoarthritis Initiative cohort

    Scientific Reports, Vol. 11, Núm. 1

  2. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

  3. Generation of mesenchymal cell lines derived from aged donors

    International Journal of Molecular Sciences, Vol. 22, Núm. 19

  4. Mitochondrial DNA from osteoarthritic patients drives functional impairment of mitochondrial activity: a study on transmitochondrial cybrids

    Cytotherapy, Vol. 23, Núm. 5, pp. 399-410

  5. Oleate Prevents Palmitate-Induced Mitochondrial Dysfunction in Chondrocytes

    Frontiers in Physiology, Vol. 12

  6. Tips and tricks for successfully culturing and adapting human induced pluripotent stem cells

    Molecular Therapy - Methods and Clinical Development, Vol. 23, pp. 569-581

2020

  1. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192

  2. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

  3. Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts

    Scientific Reports, Vol. 10, Núm. 1

  4. Generation of a human control iPS cell line (ESi080‐A) from a donor with no rheumatic diseases

    Stem Cell Research, Vol. 43

  5. Immortalizing Mesenchymal Stromal Cells from Aged Donors while Keeping Their Essential Features

    Stem Cells International, Vol. 2020